PepGen Inc.
$1.42
-0.11%PepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. The company's lead product candidate is PGN-EDO51, an EDO peptide in Phase I clinical trials to treat individuals with Duchenne muscular dystrophy (DMD). It is also developing PGN-EDODM1, an EDO peptide-conjugated PMO for the treatment of myotonic dystrophy type 1, as well as EDO therapeutic candidates, such as PGN-EDO53, PGN-EDO45, and PGN-EDO44 for the treatment of DMD. The company was founded in 2018 and is headquartered in Cambridge, Massachusetts.
At a Glance
Live SnapshotIntrinsic Alpha Methodology
Thesis Lenses
Signal
Medium confidenceValuation multiple is compressed (P/E -0.7).
Valuation inputs: P/E -0.7, earnings yield N/A, momentum -0.1%.
If multiples stay elevated while momentum fades, downside repricing risk rises.
Driver
High confidenceReturn profile is soft (ROE -60.8%, ROIC -56.9%).
Profitability stack: net margin 0.0%, ROE -60.8%, ROIC -56.9%.
Quality deterioration often appears in margins before it shows up in headline EPS.
Risk
High confidenceRisk profile is balanced but has notable pressure points to monitor.
Risk factors: liabilities/assets +15.2%, momentum -0.1%, net margin 0.0%.
Higher leverage with weak momentum and thin margins can amplify drawdown severity.
PepGen Inc. Market vs Earnings Trajectory
Loading price and EPS data...
PepGen Inc. Fair Value Envelope
No Revenue Data
PEPG has not reported any revenue values in the available annual periods.
PepGen Inc. Profit Bridge
Profitability Analysis
No Gross Profit Margin Data
PEPG has not reported any gross profit margin values in the available annual periods.
No Operating Profit Margin Data
PEPG has not reported any operating profit margin values in the available annual periods.
No Net Profit Margin Data
PEPG has not reported any net profit margin values in the available annual periods.
PepGen Inc. Cash Conversion Engine
Cash Flow Quality Analysis
FCF Conversion Rate
Strong cash conversion. Most reported earnings translate into actual cash flow, suggesting solid fundamentals.
CapEx Intensity
Asset-light business model. Low capital requirements leave more cash available for shareholders and growth investments.
FCF Growth Trend
Flat FCF growth. Stable but not expanding—monitor for signs of business maturity or temporary headwinds.
Working Capital Impact
Minimal working capital impact on FCF. Changes in operating assets and liabilities well-managed.
Cash Flow Quality Insight
Working capital strain: Significant cash tied up in operations. Monitor receivables collection, inventory turns, and payment terms to optimize cash conversion cycle.
PepGen Inc. Funding & Solvency Profile
Financial Health Analysis
Current Ratio
Excellent liquidity position. The company can easily cover its short-term obligations with substantial cushion.
Debt-to-Equity Ratio
Conservative capital structure. The company relies primarily on equity financing, indicating low financial risk.
Working Capital
Strong working capital position provides significant operational flexibility and financial cushion.
Asset Composition
Asset-light business model with high liquidity. Majority of assets are easily convertible to cash.
Financial Health Insight
Strong financial foundation: Excellent liquidity combined with conservative leverage suggests the company is well-positioned to weather economic uncertainties and fund growth opportunities.
PepGen Inc. Street Expectations Map
Wall Street analysts project that PEPG stock may rise significantly over the coming 12 months. The consensus 1-year price target stands at 5.50, with estimates ranging from a low of 4.00 to a high of 7.00.
The consensus 1-year price target stands at 5.50, with estimates ranging from a low of 4.00 to a high of 7.00.
Analyst Consensus Analysis
Upside Potential
Substantial upside potential. Analysts see significant value gap, suggesting the stock may be materially undervalued at current levels.
Analyst Agreement
Mixed analyst views. Wide target range suggests differing opinions on key value drivers, growth prospects, or risk factors.
Analyst Conviction
Bearish or uncertain outlook. Limited upside or poor consensus suggests challenges ahead or fundamental concerns.
Market Sentiment Insight
High risk, high reward: Substantial upside potential exists, but wide analyst disagreement signals execution risk or unclear catalysts. Thorough due diligence essential before committing capital.
PepGen Inc. Insider Positioning
During the last 12 months, insiders have purchased $30.78M and sold $13K worth of PEPG shares, resulting in $30.77M of net buying activity.
3 Months
0
0.00
1.2K
1.74K
-2K
-$2K
3-6 Months
0
0.00
1.8K
11.41K
-11K
-$11K
6-9 Months
9.6M
30.64M
0
0.00
+30.6M
+$30.64M
9-12 Months
96.0K
144.96K
0
0.00
+145K
+$145K
Top Buyers
Ra Capital Management, L.P.
Director, 10 Percent Owner:
$30.02M
Oxford Science Enterprises Plc
Other: Former 10% Owner
$640K
Dable Habib J
Director
$24K
Resnick Joshua
Director
$24K
Mayer Howard
Director
$24K
Top Sellers
Streck Paul
Officer: Evp, Head Of R&D
$11K
Kasraian Kasra
Officer: Chief Technical Officer
$2K
Insider Activity Analysis
Net Insider Sentiment
Strong bullish signal with $30.77M net buying. Insiders are aggressively accumulating shares, suggesting significant confidence in future prospects.
Buy/Sell Ratio
Exceptional buy/sell ratio. Buying dramatically outweighs selling—one of the strongest possible insider signals.
Recent Trend (3 Months)
Heavy recent selling activity. Recent insider sales notably exceed purchases—may warrant investigation into company developments.
Insider Participation
5 insider buyers vs. 2 sellers. Broad-based buying across management team suggests widespread confidence.
Insider Activity Insight
Compelling insider conviction: The combination of strong buy/sell ratio and multiple buyers suggests insiders see attractive risk/reward. Consider this alongside fundamental analysis for confirmation.
No Dividend Yield Data
PEPG has not reported any dividend yield values in the available annual periods.
pepg Dividend History
Learning Layer
Related Guides
Build conviction on PEPG by pairing this stock hub with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.